Perfusion Index Parameter

May 12, 2026 updated by: Medtronic - MITG

Verification of a Perfusion Index Parameter in Adult Volunteers

To evaluate the association between the Perfusion index parameter and an independent measure of perfusion.

Study Overview

Status

Completed

Detailed Description

Perfusion index parameters measured with an Investigational Pulse Oximetry PCBA, paired with Market Released sensors, will be compared to perfusion levels measured by a FDA-cleared device equipped with a laser Doppler technology-based device for blood perfusion measurements. Continuous Perfusion index measurements will be taken during the test sequence.

Study Type

Observational

Enrollment (Actual)

32

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Colorado
      • Denver, Colorado, United States, 80218
        • Medtronic Clinical Physiology Lab

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Healthy Male or Female volunteers age ≥18 years, weighing greater than 40kgs.

Description

Inclusion Criteria:

  1. Subjects ≥18 years of age
  2. Subject is able to participate for the duration of the study
  3. Subject is willing to sign an informed consent
  4. Subject weighs >40kg

Exclusion Criteria:

  1. Previous injury or trauma to fingers or hands that may change blood flow or vascular supply and affect the ability to test sensors
  2. Physiologic abnormalities that prevent proper application of pulse oximetry sensor
  3. Severe contact allergies that cause a reaction to standard adhesive materials such as those found in medical sensors and electrodes.
  4. Raynaud Syndrome
  5. Repeated systolic blood pressure > 140mmHg -

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Healthy Volunteers
Observational study

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Perfusion Index (PI) correlation to doppler measurement
Time Frame: 1 hour
To confirm correlation of Perfusion Index measured by the investigational pulse oximeter PCBA and Market Released sensors to the laser doppler measure of skin perfusion (LDSP) as determined by an overall instantaneous (lag(0)) Spearman rank correlation.
1 hour

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Randall M Clark, M.D., Medtronic Clinical Physiology Lab

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 4, 2024

Primary Completion (Actual)

September 13, 2024

Study Completion (Actual)

September 13, 2024

Study Registration Dates

First Submitted

September 4, 2024

First Submitted That Met QC Criteria

September 4, 2024

First Posted (Actual)

September 19, 2024

Study Record Updates

Last Update Posted (Actual)

May 15, 2026

Last Update Submitted That Met QC Criteria

May 12, 2026

Last Verified

September 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • MDT23025OM2VLP

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Perfusion; Complications

Subscribe